MedPath

LifeSenze Bio-Mag 41.25mg Tablet

Registration Number: MAL20126041NC

Approved
Approval ID

415ed5f05872ccb9

Registration Number

MAL20126041NC

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types5 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (5)

30 TabletsAvailable
Package Size: 30 Tablets
Status: NPRA Approved
60 TabletsAvailable
Package Size: 60 Tablets
Status: NPRA Approved
90 TabletsAvailable
Package Size: 90 Tablets
Status: NPRA Approved
120 TabletsAvailable
Package Size: 120 Tablets
Status: NPRA Approved
180 TabletsAvailable
Package Size: 180 Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

MAGNESIUM GLYCEROPHOSPHATEActive
Monograph: magnesium glycerophosphate

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LifeSenze Bio-Mag 41.25mg Tablet - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform